The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer

N Jyotsana, KT Ta, KE DelGiorno - Frontiers in oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …

Zooming in and out of ferroptosis in human disease

X Wang, Y Zhou, J Min, F Wang - Frontiers of Medicine, 2023 - Springer
Ferroptosis is defined as an iron-dependent regulated form of cell death driven by lipid
peroxidation. In the past decade, it has been implicated in the pathogenesis of various …

Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway

S Yuan, C Wei, G Liu, L Zhang, J Li, L Li, S Cai… - Cell …, 2022 - Wiley Online Library
Objectives Evidences demonstrate that sorafenib alleviates liver fibrosis via inhibiting HSC
activation and ECM accumulation. The underlying mechanism remains unclear. Ferroptosis …

HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis

Y Tan, Y Huang, R Mei, F Mao, D Yang, J Liu… - Cell death & …, 2022 - nature.com
Activated hepatic stellate cells (HSCs) are significant in liver fibrosis. Our past investigations
have shown that human umbilical cord mesenchymal stem cells (hucMSCs) and their …

m6A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells

M Shen, M Guo, Y Li, Y Wang, Y Qiu, J Shao… - Free Radical Biology …, 2022 - Elsevier
Activation of hepatic stellate cells (HSCs) is a central event in the development of liver
fibrosis, and the elimination of activated HSCs is considered to be an effective anti-fibrotic …

Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice

S Huang, Y Wang, S Xie, Y Lai, C Mo, T Zeng, S Kuang… - Phytomedicine, 2022 - Elsevier
Background Liver fibrosis is a major disease that threatens people's health around the
world. However, there is a lack of effective treatment to completely reverse liver fibrosis …

Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis

N Yamada, T Karasawa, J Ito, D Yamamuro… - Nature …, 2024 - nature.com
Recent evidence indicates ferroptosis is implicated in the pathophysiology of various liver
diseases; however, the organ-specific regulation mechanism is poorly understood. Here, we …

Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis

K Du, R Maeso-Díaz, SH Oh, E Wang, T Chen… - Hepatology, 2023 - journals.lww.com
Conclusion: YAP determines whether MF-HSCs remain activated or become senescent. By
regulating this state transition, Yap controls both HSC fibrogenic activity and susceptibility to …

Role of Caveolin-1 on the molybdenum and cadmium exposure induces pulmonary ferroptosis and fibrosis in the sheep

T Zhang, F Yang, X Dai, H Liao, H Wang, C Peng… - Environmental …, 2023 - Elsevier
Molybdenum (Mo) is an essential trace element that exists in all tissues of the human body,
but excessive Mo intake has a toxic effect. Cadmium (Cd) is a widely known and harmful …

Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis

SS Cho, JH Yang, JH Lee, JS Baek, SK Ku… - Free Radical Biology …, 2022 - Elsevier
Ferroptosis is a widely known regulator of cell death in connection with the redox state as a
consequence of the depletion of glutathione or accumulation of lipid peroxidation. Hepatic …